WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Results 1-10 of 216 for Criteria: Office(s):all Language:FR Stemming: true maximize
préc. 1 2 3 4 5 6 7 8 9 10 suiv.
Page: / 22  Go >
RSS iconmap icon 

Analysis
Analysis

List Length
Machine translation
TitleCtrPubDate
Int.ClassAppl.NoApplicantInventor
1. WO/2004/039722 METHOD FOR PRODUCTION OF NITRATE-CONTAINING PRODUCTS FROM UNDERCOOLING MELTSWO13.05.2004
C01B 21/48
PCT/NO2002/000400YARA INTERNATIONAL ASAISAKSEN, Jan, Birger
The invention concerns a method for the production of nitrate containing products (fertilizers, technical products) from undercooling melts, wherein a XN - water solution is evaporated up to a content of 50-99.8 weight % XN, where X is one or more selected from Ca, Mg, NH4, Na and K, and N means nitrate. The preferred range of XN is 70-99.5 weight %. The melt is cooled down to and kept at a temperature at or below the crystallisation point and finely divided solid XN powder consisting of the equilibrium phases is added to the melt. Melt drops are then formed and allowed to cool and solidify during up to 70 seconds. It is preferred to use a cooling belt for solidification of the particles. The belt is cooled by air, water, oil or another medium.

2. WO/2004/026807 INTERMEDIATES IN PRODUCING PHENOXYACETIC ACID DERIVATIVES AND METHOD OF USING THE SAMEWO01.04.2004
A61L 15/40
PCT/JP2002/009034KISSEI PHARMACEUTICAL CO., LTD.TANAKA, Nobuyuki
Intermediates represented by the following general formula (I), etc. which are useful in producing phenoxyacetic acid derivatives represented by the following general formula (X) or pharmaceutically acceptable salts thereof having an effect of stimulating β3-adrenalin receptor and being useful as preventives or remedies for obesity, hyperglycemia, diseases caused by enteric movement disorders, urinary frequency, urinary incontinence, depression or biliary calculus; a process for producing these intermediates; and a method of using the same: (I) (X) wherein R1 and R2 independently represent each lower alkyl.

3. WO/2003/083232 DOUBLY PRESTRESSED ROOF-CEILING CONSTRUCTION WITH GRID FLAT-SOFFIT FOR EXTREMELY LARGE SPANSWO09.10.2003
E04B 7/02
PCT/HR2002/000058MARA-INSTITUT D.O.O.SKENDZIC, Milovan
The doubly prestressed roof-ceiling construction with grid flat soffit for extremely large-span is prefabricated element intended for assembling roofs of extremely large-span buildings with flat soffit. The construction comprises the grid soffit construction (1) and the upper concrete girder (2) of a modified 'T' shaped or of an inverse 'V' shaped cross section, interconnected by slender steel pipe-rods (3) that stabilize the upper girder (2) against lateral buckling. The empty openings within elements of the horizontal grid (1) are fulfilled with plates (6) wherewith a flat soffit is achieved. The construction is prestressed by the double prestressing. The grid-soffit (1) is prestressed centrically and the upper girder (2) is prestressed by the wedge (5) at the midspan.

4. WO/2003/059144 METHOD AND PROCESS FOR PRODUCING YOUTHFUL-APPEARING, SMALL-PORED, AND SMOOTH SKINWO24.07.2003
A61B 17/00
PCT/US2002/027570PARSONS, Diana, J.PARSONS, Diana, J.
The method and process for producing youthful appearing, small-pored, and smooth skin comprises pretreating the skin topically with retinoic acid, applying a contaminate in oil to the skin, and removing the contaminate by exploding or rupturing it with laser light. When treating the face, removing the contaminate requires only about 4 minutes. The laser light itself does not injure the skin but the rupture of the contaminant produces thermal injury in the high dermis leaving the epidermis intact. Repeated intermittent laser treatments and applications of topical retinoic acid produces the desired results in the skin indefinitely as long as the treatments and applications are continued.

5. WO/2003/060253 INDIRECTLY PRESTRESSED, CONCRETE, ROOF-CEILING CONSTRUCTION WITH FLAT SOFFITWO24.07.2003
E04B 7/02
PCT/HR2002/000057MARA-INSTITUT D.O.O.SKENDZIC, Milovan
The indirectly prestressed concrete roof-ceiling construction is prefabricated element for constructing industrial large-span buildings. The construction comprises distinctly wide and thin concrete soffit plate (1) and upper concrete girder (2), of the inverse 'V'-shaped cross section, interconnected by slender steel pipe-rods (3) that are used to stabilize the upper girder (2) against lateral buckling and to prevent parts (1) and (2) to get closer or apart each to another. Prestressing of the soffit plate (1) causes compression in the upper girder (2) which passively (indirectly) pushes the ends of the construction, acting on some eccentricity over the center of gravity of the cross section, causing rotation of its ends bending in that way the soffit plate upwards. There are two efficient methods of prestressing these constructions.

6. WO/2003/057211 COMPOSITION INHIBITING MATRIX-METALLPROTEINASES FOR THE TREATMENTOF NEOPLASTIC DISEASES.WO17.07.2003
A61K 31/198
PCT/EP2002/001005RATH, MatthiasRATH, Matthias
The present invention relates to a composition comprising a catechin compound, ascorbic acid, proline and lysine. The present invention also relates to a method for treating neoplastic disease using a composition comprising a catechin compound, ascorbic acid, proline and lysine.

7. WO/2003/051371 COMPOSITION OF ESTROGEN AND OTHER HORMONES WITH ASCORBATE, LYSINE, PROLINE AND OTHER SUBSTANCESWO26.06.2003
A61K 31/375
PCT/EP2001/014726RATH, MatthiasRATH, Matthias
This invention concerns compositions of estrogen and related hormones in combination with ascorbate, lysine, proline and other substances effecting connective tissues, their ability and their use in contraception, hormonal replacement therapy during menopause, and for other use in medicine, physiology, pharmacology, pharmaceuticals and cosmetic application.

8. WO/2003/047587 PLATINUM DERIVATIVE PHARMACEUTICAL FORMULATIONSWO12.06.2003
A61K 31/519
PCT/EP2002/013146PHARMACIA ITALIA S.P.A.LAURIA, Sara
The present invention relates to novel stable solution formulations comprising oxaliplatin, an effective stabilizing amount of lactic acid and/or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable carrier. A method for manufacturing such formulations ready for administration and their use in the antitumor therapy are also within the scope of the invention.

9. WO/2003/045372 FORMULATION OF AMINO ACIDS AND RIBOFLAVIN USEFUL TO REDUCE TOXIC EFFECTS OF CYTOTOXIC CHEMOTHERAPYWO05.06.2003
A61K 31/195
PCT/US2002/037354BURZYNSKI, Stanislaw, R.BURZYNSKI, Stanislaw, R.
Pharmaceutical compositions effective in alleviating or reducing the effects of fatigue and weakness associated with cancer and cytotoxic cancer chemotherapy are disclosed. The pharmaceutical compositions of the present invention comprise riboflavin, effectors of the urea cycle in free form or pharmacologically acceptable salts thereof, and amino acids selected from the gorups of essential and non-essential amino acids, in free form or pharmaceutically acceptable salts thereof, suitably combined with appropriate carriers, diluents, or excipients. Also disclosed are methods of alleviating or reducing the effects of fatigue and weakness associated with cancer and cytotoxic cancer chemotherapy by administration of pharmaceutical compositions of the present invention.

10. WO/2003/043661 PREPARATION COMPOSITIONS CONTAINING ACID-UNSTABLE PHYSIOLOGICALLY ACITVE COMPOUNDS AND PROCESS FOR PRODUCING THE SAMEWO30.05.2003
A61K 9/28
PCT/JP2002/012132EISAI CO., LTD.AOKI, Shigeru
It is intended to disclose preparation compositions which enable convenient production of sustained-release preparation compositions containing acid-unstable physiologically active compounds and have the desired sustained-release properties. Namely, preparation compositions comprising a core containing an acid-unstable physiologically active compound and a film with which the core is coated and which contains a mixture of a water-insoluble polymer with an enteric polymer. These preparation compositions make it possible to maintain an effective concentration in blood of the physiologically active compound over a long time, thereby improving its therapeutic effect. Moreover, these compositions remain stable over prolonged storage.


Results 1-10 of 216 for Criteria: Office(s):all Language:FR Stemming: true
préc. 1 2 3 4 5 6 7 8 9 10 suiv.